Sarcoma and Soft Tissue Oncology Program
Rutgers Cancer Institute Sarcoma and Soft Tissue Oncology program provides comprehensive multidisciplinary care to patients with soft tissue sarcomas, osteosarcoma, Ewing sarcoma, Kaposi sarcoma, uterine sarcomas, gastrointestinal stromal tumors (GIST) and others.
Ganesan Army Breakthrough Award Feb 2021
$1.33 Million Award Supports Research to Better Inform HER2 Breast Cancer Treatment
A Rutgers Cancer Institute collaboration with George Mason University received the U.S. Army’s Breast Cancer Research Program Breakthrough Award to quickly confirm if an identified HER2 biomarker can indicate success likelihood of personalized treatments. Read more
Cancer Metabolism
.coe{
font: normal 24px Trebuchet MS,sans-serif;
color: #cc0033;
padding: 6px 0;
}
Breaking Through the Latest Breakthroughs.
Good Manufacturing Practices (GMP)
.coe{
font: normal 24px Trebuchet MS,sans-serif;
color: #cc0033;
padding: 6px 0;
}
In-House Technology.
Cell Therapy
.coe{
font: normal 24px Trebuchet MS,sans-serif;
color: #cc0033;
padding: 6px 0;
}
Further Advancing the Latest Technology.
Immune Checkpoint Blockade
.coe{
font: normal 24px Trebuchet MS,sans-serif;
color: #cc0033;
padding: 6px 0;
}
How does cancer “work?”
Center of Excellence in Cancer Immunology and Metabolism Membership
.divTable{
display: table;
width: 100%;
}
.divTableRow {
display: table-row;
}
.divTableHeading {
background-color: #EEE;
display: table-header-group;
}
.divTableCell, .divTableHead {
display: table-cell;
padding: 3px 10px;
height: auto;
width: 100%;
}
.divTableBody {
display: table-row-group;
}
{
box-sizing: border-box;
}
/* Create two equal columns that float next to each other */
.column {
float: left;
width: 33%;
padding: 20px;
}
/* Clear floats after the columns */
.row:after {
content: "";
display: table;
clear: both;
}
/* On screens